Answers are grounded in this paper and cite their sources.
The diagnosis of antibody-mediated rejection has become more common and represents a major cause of kidney graft loss.The ideal treatment remains unknown, with little evidence supporting the use of a specific therapy.The definition of antibody-mediated rejection is based on serologic (presence and/or development of donor-specific antibodies) and histologic (evidence of acute tissue injury with C4d deposition or other signs of antibody interaction with the vascular endothelium) criteria.Antibody-mediated rejection without donor-specific antibodies is a subcategory with a defying diagnosis.This particularly entity is increasingly being reported as an important cause of allograft dysfunction in kidney transplantation.We describe the case of a kidney transplant recipient with a low immunological risk and delayed graft function due to an antibody-mediated rejection with negative donor-specific antibodies.
No takes yet. Share an insight, caveat, or question.
A 2023 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: